Impact of substance P on cellular immunity

Journal of Biological Regulators and Homeostatic Agents

Volumn 22, Issue 2, 2008, Pages 93-98

  Katsanos, G S ^a   Anogeianaki, A ^a   Orso, C ^a   Tete S ^a   Salini, V ^a   Antinolfi, P L ^b   Sabatino, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Mast cells; Neuromodulator; Neurotransmitter molecules; Substance P

Indexed keywords

ALPHA CHEMOKINE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SUBSTANCE P; SUBSTANCE P ANTAGONIST; TACHYKININ RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ADHESION; CELL COMMUNICATION; CELL PROLIFERATION; CELL PROTECTION; CELLULAR IMMUNITY; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EDITORIAL; GASTROESOPHAGEAL REFLUX; GLIOMA; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; LYMPHOCYTE MIGRATION; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; HEMATOPOIESIS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; LYMPHOCYTES; RECEPTORS, TACHYKININ; SUBSTANCE P;

EID: 48749109343     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (41)

1. Martin AL, Schwartz MD, Jameson SC, Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110gamma isoform of phosphatidylinositol 3-kinase. J Immunol 2008; 180(4):2081-8.
2. Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008; 255 (S1):3-11.
3. di Lorenzo L, Vacca A, Corfiati M, Lovreglio P, Soleo L. Evaluation of tumor necrosis factor-alpha and granulocyte colony-stimulating factor serum levels in lead-exposed smoker workers. Int J Immunopathol Pharmacol 2007; 20:239-247.
4. Castellani ML, Bhattacharya K, Tagen M, Kempuraj D, Perrella A, De Lutiis M, Boucher W, Conti P, Theoharides TC. Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 2007; 20:447-453.
5. Rosati E, Mencarelli S, Magini A, Sabatini R, Tassi C, Orlacchio A, Coaccioli S, Frenguelli A, Marconi P, Emiliani C. Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis. Int J Immunopathol Pharmacol 2007; 20:279-288.
6. Anisman H, Baines MG, Berczi I, Bernstein CN, Blennerhassett MG, Gorczynski RM, Greenberg AH, Kisil FT, Mathison RD, Nagy E, Nance DM, Perdue MH, Pomerantz DK, Sabbadini ER, Stanisz A, Warrington RJ. Neuroimmune mechanisms in health and disease: 1. Health. CMAJ 1996; 155:867-74.
7. Luger TA, Bhardwaj RS, Grabbe S, Schwarz T. Regulation of the immune response by epidermal cytokines and neurohormones. J Dermatol Sci 1996; 13:5-10.
8. Leeman SE, Ferguson SL. Substance P: an historical perspective. Neuropeptides 2000; 34:249-54.
9. Boyd ND, MacDonald SG, Kage R, Luber-Narod J, Leeman SE. Substance P receptor. Biochemical characterization and interactions with G proteins. Ann NY Acad Sci 1991; 632:79-93.
10. Chancellor-Freeland C, Zhu GF, Kage R, Beller DI, Leeman SE, Black PH. Substance P and stress-induced changes in macrophages. Ann N Y Acad Sci 1995; 771:472-84.
11. Ikeda Y, Takei H, Matsumoto C, Mase A, Yamamoto M, Takeda S, Ishige A, Watanabe K. Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Arch Dermatol Res 2007; 299:345-51.
12. D'Offizi G, Gioia C, Corpolongo A, Martini F, Paganelli R, Volpi I, Sacchi A, Tozzi V, Narciso P, Poccia F. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects. Int J Immunopathol Pharmacol 2007; 20:473-485.
13. Bell LV, Else KJ. Mechanisms of leucocyte recruitment to the inflamed large intestine: redundancy in integrin and addressin usage. Parasite Immunol 2008; 30:163-70.
14. Mayerhofer M, Aichberger KJ, Florian S, Valent P. Recognition-sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Int J Immunopathol Pharmacol 2007; 20:421-434.
15. Feliciani C, Ruocco E, Zampetti A, Toto P, Amerio Pa, Tulli A, Amerio P, Ruocco V. Tannic acid induces in vitro acantholysis of keratinocytes via IL-1α and TNF-α. Int J Immunopathol Pharmacol 2007; 20: 289-300.
16. Ventura MT, Sanapo F, Calogiuri GF, Satriano F. Anaphylaxis induced by intramuscular betamethasone disodium phosphate: reflections on a clinical case. Int J Immunopathol Pharmacol 2007; 20:387-392.
17. Staniek V, Misery L. Substance P and human skin. Pathol Biol (Paris) 1996; 44:860-6.
18. Shaik YB, Castellani ML, Perrella A, Conti F, Salini V, Tetà S, Madhappan B, Vecchiet J, De Lutiis MA, Caraffa A, Cerulli G. Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents 2006; 20:47-52.
19. Zhu W, Mundane KJ, Kream RM, Cadet P, Stefano GB. Cholinergic regulation of morphine release from human white blood cells: evidence for a novel nicotinic receptor via pharmacological and microarray analysis. Int J Immunopathol Pharmacol 207; 30:229-238.
20. Paulus WJ. Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure. J Card Fail 1996; 2:S155-64.
21. Negrev NN, Radev RZ, Velikova MS, Anogeianaki A. Screening study of the effects of the hypothalamicpituitary-thyroid axis on hemostasis in rats. J Biol Regul Homeost Agents 2006; 20:53-58.
22. Bocchietto E, Paolucci C, Breda D, Sabbioni E, Burastero SE. Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals. Int J Immunopathol Pharmacol 2007; 20:259-266.
23. Garbuglia AR, Grasso F, Donà MG, Mochi S, Conti P, De Lutiis MA, Giorgi C Iezzi T. TTV infection: role of IFNs, IL-28 and IL-29 cytokines, antiviral proteins. Int J Immunopathol Pharmacol 2007; 20: 249-258.
24. Ou R, Zhang M, Huang L, Flavell RA, Koni PA, Moskophidis D. Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. J Virol 2008;82:2952-65.
25. Pannone G, Sanguedolce F, De Maria S, Farina E, Lo Muzio L, Serpico R, Emanuelli M, Rubini C, De Rosa G, Staibano S, Macchia L, Bufo P. Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. Int J Immunopathol Pharmacol 2007; 20:317-324.
26. Shim JY, Han Y, Ahn JY, Yun YS, Song JY. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice. Int J Immunopathol Pharmacol 2007; 20:487-497.
27. Chung KO. Effects of nedocromil sodium on airway neurogenic mechanisms. J Allergy Clin Immunol 1996; 98:S112-6.
28. Dimri R, Sharabi Y, Shoham J. Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P. J Immunol 2000; 164:2479-86.
29. Koon HW, Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 2006; 1088:23-40.
30. Corcoran KE, Patel N, Rameshwar P. Stromal derived growth factor-1alpha: another mediator in neural-emerging immune system through Tac1 expression in bone marrow stromal cells. J Immunol. 2007; 178:2075-82.
31. Capodiferro S, Scully C, Ficarra G, de Frenza G, Grassi R, Maiorino E, Favia G, Mastrangelo F, Tetè S. Orofacial granulomatosis: report of two cases with gingival onset. Eur J Inflamm 2007; 5:51-56.
32. Ciprandi G, Cirillo I, Troisi RM, Marseglia GL. Allergic subjects have more numerous respiratory infections and severe gastrointestinal infections than non-allergic subjects: preliminary results. Eur J Inflamm 2007; 5:27-29.
33. Ahangari G, Chavoshzadeh Z, Lari Z, Ramyar A, Farhoudi A. Novel mutation detection of an inflammatory molecule Elastase II gene encoding neutrophil Elastase in Kostmann syndrome. Eur J Inflamm 2007; 5:65-71.
34. Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman SE, Kirkland JL, Pothoulakis C. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 2006; 103(13):5207-12.
35. Papoff P, Mancuso M, Barbàra CS, Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. Int J Immunopathol Pharmacol 2007; 20:213-222.
36. Hauswirth AW, Sonneck K, Florian ST, Krauth MT, Böhm A, Sperr WR, Valenta R, Schemthaner G-H, Printz D, Fritsch G, Bühring H-J, Valent P. Interleukin-3 promotes the expression of enpp3/cd203c on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol 2007; 20:267-278.
37. Madonna R, Massaro M, Pandolfi A, Consoli A, Caterina RD. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int J Immunopathol Pharmacol 2007; 20:539-555.
38. Rameshwar P. Implication of possible therapies targeted for the tachykinergic system with the biology of neurokinin receptors and emerging related proteins. Recent Patents CNS Drug Discov 2007; 2: 79-84.
39. Misery L. Neuro-immuno-cutaneous system (NICS). Pathol Biol (Paris) 1996; 44:867-74.
40. Thomson LM, Terman GW, Zeng J, Lowe J, Chavkin C, Hermes SM, Hegarty DM, Aicher SA. Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats. J Pain 2008; 9:11-9.
41. Caudle RM, Mannes AJ, Keller J, Perez FM, Suckow SK, Neubert JK. Sensitization of spinal cord nociceptive neurons with a conjugate of substance P and cholera toxin. BMC Neurosci 2007; 10:8-30.